XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
2022 Notes
Common Stock
2025 Notes
Common Stock
Cumulative effect adjustment due to adoption of ASU 2020-06
Common Stock
Additional Paid-In Capital
2022 Notes
Additional Paid-In Capital
2025 Notes
Additional Paid-In Capital
Cumulative effect adjustment due to adoption of ASU 2020-06
Additional Paid-In Capital
Accumulated Deficit
2022 Notes
Accumulated Deficit
2025 Notes
Accumulated Deficit
Cumulative effect adjustment due to adoption of ASU 2020-06
Accumulated Deficit
Accumulated Other Comprehensive Loss
2022 Notes
Accumulated Other Comprehensive Loss
2025 Notes
Accumulated Other Comprehensive Loss
Cumulative effect adjustment due to adoption of ASU 2020-06
Accumulated Other Comprehensive Loss
2022 Notes
2025 Notes
Cumulative effect adjustment due to adoption of ASU 2020-06
Total
Balance as of beginning of the period at Dec. 31, 2020       $ 150,000       $ 16,857,797,000       $ (992,661,000)       $ 18,518,000       $ 15,883,804,000
Balance as of beginning of the period (in shares) at Dec. 31, 2020       150,281,099                                
Stockholders' Equity (Deficit)                                        
Exercise of stock options       $ 3,000       22,953,000       0       0       22,956,000
Exercise of stock options (in shares)       2,123,935                                
Issuance of common stock upon vesting of restricted stock units       $ 1,000       (1,000)       0       0       0
Issuance of common stock upon vesting of restricted stock units (in shares)       1,490,879                                
Issuance of stock under employee stock purchase plan       $ 0       10,539,000       0       0       10,539,000
Issuance of stock under employee stock purchase plan (in shares)       82,088                                
Issuance of common stock for Notes $ 1,000 $ 5,000     $ 270,111,000 $ 920,514,000     $ 0 $ 0     $ 0 $ 0     $ 270,112,000 $ 920,519,000    
Issuance of common stock for Notes (in shares) 1,058,373 5,182,656                                    
Recovery of excess common stock issued for acquisition       $ 0       (40,329,000)       0       0       (40,329,000)
Recovery of excess common stock issued for acquisition (in shares)       (205,279)                                
Equity portion of extinguishment of Notes $ 0 $ 0     $ (224,081,000) (668,507,000)     $ 0 0     $ 0 0     $ (224,081,000) (668,507,000)    
Stock-based compensation       $ 0       250,027,000       0       0       250,027,000
Other comprehensive loss, net of tax       0       0       0       (19,650,000)       (19,650,000)
Net loss       0       0       (417,808,000)       0       (417,808,000)
Balance as of end of the period at Sep. 30, 2021       $ 160,000       17,399,023,000       (1,410,469,000)       (1,132,000)       15,987,582,000
Balance as of end of the period (in shares) at Sep. 30, 2021       160,013,751                                
Balance as of beginning of the period at Jun. 30, 2021       $ 159,000       17,314,749,000       (1,326,129,000)       12,291,000       16,001,070,000
Balance as of beginning of the period (in shares) at Jun. 30, 2021       159,462,978                                
Stockholders' Equity (Deficit)                                        
Exercise of stock options       $ 1,000       5,174,000       0       0       5,175,000
Exercise of stock options (in shares)       216,882                                
Issuance of common stock upon vesting of restricted stock units       $ 0       0       0       0       0
Issuance of common stock upon vesting of restricted stock units (in shares)       235,674                                
Issuance of common stock for Notes   $ 0       14,868,000       0       0       14,868,000    
Issuance of common stock for Notes (in shares)   98,217                                    
Equity portion of extinguishment of Notes   $ 0       (10,079,000)       0       0       (10,079,000)    
Stock-based compensation       $ 0       74,311,000       0       0       74,311,000
Other comprehensive loss, net of tax       0       0       0       (13,423,000)       (13,423,000)
Net loss       0       0       (84,340,000)       0       (84,340,000)
Balance as of end of the period at Sep. 30, 2021       $ 160,000       17,399,023,000       (1,410,469,000)       (1,132,000)       15,987,582,000
Balance as of end of the period (in shares) at Sep. 30, 2021       160,013,751                                
Balance as of beginning of the period at Dec. 31, 2021     $ 0 $ 160,000     $ (363,731,000) 17,473,336,000     $ 72,698,000 (1,421,454,000)     $ 0 (6,285,000)     $ (291,033,000) 16,045,757,000
Balance as of beginning of the period (in shares) at Dec. 31, 2021     0 160,469,325                                
Stockholders' Equity (Deficit)                                        
Exercise of stock options       $ 1,000       5,645,000       0       0       $ 5,646,000
Exercise of stock options (in shares)       552,400                               552,400
Issuance of common stock upon vesting of restricted stock units       $ 1,000       (1,000)       0       0       $ 0
Issuance of common stock upon vesting of restricted stock units (in shares)       1,025,363                                
Issuance of stock under employee stock purchase plan       $ 0       4,225,000       0       0       4,225,000
Issuance of stock under employee stock purchase plan (in shares)       148,609                                
Issuance of common stock for Notes   $ 0       7,000       0       0       7,000    
Issuance of common stock for Notes (in shares)   93                                    
Equity portion of extinguishment of Notes   $ 0       $ (2,000)       $ 0       $ 0       $ (2,000)    
Stock-based compensation       $ 0       180,502,000       0       0       180,502,000
Other comprehensive loss, net of tax       0       0       0       (42,981,000)       (42,981,000)
Net loss       0       0       (9,849,460,000)       0       (9,849,460,000)
Balance as of end of the period at Sep. 30, 2022       $ 162,000       17,299,981,000       (11,198,216,000)       (49,266,000)       6,052,661,000
Balance as of end of the period (in shares) at Sep. 30, 2022       162,195,790                                
Balance as of beginning of the period at Jun. 30, 2022       $ 162,000       17,239,092,000       (11,124,740,000)       (29,864,000)       6,084,650,000
Balance as of beginning of the period (in shares) at Jun. 30, 2022       161,892,008                                
Stockholders' Equity (Deficit)                                        
Exercise of stock options       $ 0       666,000       0       0       666,000
Exercise of stock options (in shares)       125,039                                
Issuance of common stock upon vesting of restricted stock units       $ 0       0       0       0       0
Issuance of common stock upon vesting of restricted stock units (in shares)       178,743                                
Stock-based compensation       $ 0       60,223,000       0       0       60,223,000
Other comprehensive loss, net of tax       0       0       0       (19,402,000)       (19,402,000)
Net loss       0       0       (73,476,000)       0       (73,476,000)
Balance as of end of the period at Sep. 30, 2022       $ 162,000       $ 17,299,981,000       $ (11,198,216,000)       $ (49,266,000)       $ 6,052,661,000
Balance as of end of the period (in shares) at Sep. 30, 2022       162,195,790